Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection

Romain Désert(Inserm), Orlando Musso(Inserm), Marie Sicard(Inserm), Frédéric Canal(Délégation Paris 5), Florian Rohart(Translational Research Institute), Bruno Clément(Inserm), Bruno Turlin(Inserm), Stéphanie Renaud(Inserm), Kim‐Anh Lê Cao(The University of Melbourne), Mireille Desille(Inserm), Pascale Bellaud(Centre National de la Recherche Scientifique), Christine Perret(Institut de Cancérologie de l'Ouest)
Hepatology
May 12, 2017
Cited by 127


Related Papers